financetom
Business
financetom
/
Business
/
Intermap Reports $1 Million Program in Malaysia, Provides Other Business Updates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intermap Reports $1 Million Program in Malaysia, Provides Other Business Updates
Mar 25, 2024 6:10 AM

08:50 AM EDT, 03/25/2024 (MT Newswires) -- Intermap Technologies ( ITMSF ) , a global player in 3D geospatial products and intelligence services, said Monday that it has won a $1 million contract in Malaysia to enhance water resources management.

Intermap ( ITMSF ) has secured more than $15 million under Malaysia's current basemap program and expects the awards to continue.

Also, the company said it has secured the first payment for the Indonesian mapping program and reported significant progress in project preparations and deployment. The program is now underway to capture and analyze intricate geospatial data.

Regarding Intermap's ( ITMSF ) global insurance business, the company said it has reached $1 million from a new client subscription and multiple renewals.

Intermap ( ITMSF ) will release its audited annual financial statements for the year ended Dec. 31, 2023, on April 1.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Looking At Salesforce's Recent Unusual Options Activity
Looking At Salesforce's Recent Unusual Options Activity
Apr 24, 2024
Whales with a lot of money to spend have taken a noticeably bearish stance on Salesforce ( CRM ). Looking at options history for Salesforce ( CRM ) we detected 17 trades. If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 47% with bearish. From...
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
Apr 24, 2024
The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing  Novo Nordisk ( NVO ) A/S ‘s pricing strategies, particularly those of its diabetes and obesity medications, Ozempic and Wegovy. Senator Bernie Sanders emphasized the necessity of reducing prices to ensure accessibility for consumers and sustainability for governments. Senator Sanders penned a letter to Novo Nordisk’s CEO, Lars Fruergaard Jorgensen, demanding...
Top Midday Gainers
Top Midday Gainers
Apr 24, 2024
02:25 PM EDT, 04/24/2024 (MT Newswires) -- BranchOut Food ( BOF ) said Wednesday it has expanded its relationship with the nation's largest retailer, bringing the total annualized value of commitments from the retailer to over $8.0 million annually. Shares surged 59% as intraday trading volume climbed to more than 100.6 million versus a daily average of about 72,000. B....
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Apr 24, 2024
Nine months after the U.S. launch of Eisai Limited (OTC:ESALY) and Biogen Inc’s Leqembi, the first drug shown to slow Alzheimer’s progression, adoption faces hurdles due to skepticism among some doctors.  Initially hopeful, Alzheimer’s experts anticipated challenges with Leqembi’s requirements, including frequent infusions and diagnostic tests, leading to slow adoption after FDA approval.  Interviews with 20 neurologists and geriatricians revealed concerns about efficacy, costs, and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved